FATE financials
Fate Therapeutics (FATE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- FATE revenue was $6.65M in fiscal 2025, net income -$136.31M.
FATE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $6.65M | – | -$147.70M | -$136.31M | -1.15 |
| 2024 | $13.63M | – | -$210.28M | -$186.26M | -1.64 |
| 2023 | $63.53M | – | -$190.51M | -$160.93M | -1.64 |
| 2022 | $96.30M | – | -$308.39M | -$281.72M | -2.91 |
| 2021 | $55.85M | – | -$216.99M | -$212.15M | -2.24 |
| 2020 | $31.43M | – | -$128.09M | -$173.39M | -2.10 |